References
1. Wolfson JA, Schrager SM, Coates TD, Kipke MD. Sickle-cell disease in
California: A population-based description of emergency department
utilization. Pediatric Blood & Cancer. 2011;56(3):413-419.
2. CDC Sickle Cell Disease home page - data and statistics - last
accessed 2-18-2020.
https://www.cdc.gov/ncbddd/sicklecell/data.html
3. Wojciechowski EA, Hurtig A, Dorn L. A natural history study of
adolescents and young adults with sickle cell disease as they transfer
to adult care: A need for case management services. Journal of
Pediatric Nursing. 2002;17(1):18-27.
4. Yanni E, Grosse SD, Yang Q, Olney RS. Trends in Pediatric Sickle Cell
Disease-Related Mortality in the United States, 1983-2002. The
Journal of Pediatrics. 2009;154(4):541-545.
5. Elmariah H, Garrett ME, De Castro LM, et al. Factors associated with
survival in a contemporary adult sickle cell disease cohort.American Journal of Hematology. 2014;89(5):530-535.
6. Shankar SM, Arbogast PG, Mitchel E, Cooper WO, Wang WC, Griffin MR.
Medical care utilization and mortality in sickle cell disease: A
population-based study. American Journal of Hematology.2005;80(4):262-270.
7. Quinn CT, Rogers ZR, McCavit TL, Buchanan GR. Improved survival of
children and adolescents with sickle cell disease. Blood.2010;115(17):3447-3452.
8. Lanzkron S, Sawicki GS, Hassell KL, Konstan MW, Liem RI, McColley SA.
Transition to adulthood and adult health care for patients with sickle
cell disease or cystic fibrosis: Current practices and research
priorities. Journal of Clinical and Translational Science.2018;2(5):334-342.
9. Mainous AG, Rooks B, Tanner RJ, Carek PJ, Black V, Coates TD. Shared
Care for Adults with Sickle Cell Disease: An Analysis of Care from Eight
Health Systems. Journal of Clinical Medicine. 2019;8(8):1154.
10. Mainous AG, Tanner RJ, Harle CA, Baker R, Shokar NK, Hulihan MM.
Attitudes toward Management of Sickle Cell Disease and Its
Complications: A National Survey of Academic Family Physicians.Anemia. 2015;2015:1-6.
11. Debaun MR, Telfair J. Transition and Sickle Cell Disease.Pediatrics. 2012;130(5):926-935.
12. Treadwell M, Telfair J, Gibson RW, Johnson S, Osunkwo I. Transition
from pediatric to adult care in sickle cell disease: Establishing
evidence-based practice and directions for research. American
Journal of Hematology. 2011;86(1):116-120.
13. Aisiku IP, Penberthy LT, Smith WR, et al. Patient satisfaction in
specialized versus nonspecialized adult sickle cell care centers: the
PiSCES study. J Natl Med Assoc. 2007;99(8):886-890.
14. Wolfson JA, Schrager SM, Khanna R, Coates TD, Kipke MD. Sickle cell
disease in California: Sociodemographic predictors of emergency
department utilization. Pediatric Blood & Cancer.2012;58(1):66-73.
15. Brousseau DC. Acute Care Utilization and Rehospitalizations for
Sickle Cell Disease. JAMA. 2010;303(13):1288.
16. Jordan L, Swerdlow P, Coates TD. Systematic review of transition
from adolescent to adult care in patients with sickle cell disease.J Pediatr Hematol Oncol. 2013;35(3):165-169.
17. McPherson M, Thaniel L, Minniti CP. Transition of patients with
sickle cell disease from pediatric to adult care: Assessing patient
readiness. Pediatric Blood & Cancer. 2009;52(7):838-841.
18. Wang CJ, Kavanagh PL, Little AA, Holliman JB, Sprinz PG.
Quality-of-Care Indicators for Children With Sickle Cell Disease.Pediatrics 2011;128(3):484-493.
19. Sobota AE, Shah N, Mack JW. Development of quality indicators for
transition from pediatric to adult care in sickle cell disease: A
modified Delphi survey of adult providers. Pediatric Blood &
Cancer. 2017;64(6):e26374.
20. Anderson LA, Dedrick RF. Development of the trust in physician
scale: a measure to assess interpersonal trust in patient-physician
relationships Psychol Rep. 1990;67(3 Pt 2):1091-1100.
21. Marshall GN and Hays R.D. The patient satisfaction
questionnaire short form (PSQ-18). Santa Monica, CA: RAND
Corporation;1994.
22. Thayaparan AJ, Mahdi E. The Patient Satisfaction Questionnaire Short
Form (PSQ-18) as an adaptable, reliable, and validated tool for use in
various settings. Medical Education Online. 2013;18(1):21747.
23. Lunyera J, Jonassaint C, Jonassaint J, Shah N. Attitudes of Primary
Care Physicians Toward Sickle Cell Disease Care, Guidelines, and
Comanaging Hydroxyurea With a Specialist. Journal of Primary Care
& Community Health. 2017;8(1):37-40.
24. Whiteman LN, Haywood C, Jr., Lanzkron S, Strouse JJ, Feldman L,
Stewart RW. Primary Care Providers’ Comfort Levels in Caring for
Patients with Sickle Cell Disease. South Med J.2015;108(9):531-536.
25. Lanzkron S, Little J, Field J, et al. Increased acute care
utilization in a prospective cohort of adults with sickle cell disease.Blood Advances. 2018;2(18):2412-2417.
26. Sobota A, Umeh E, Mack J. Young Adult Perspectives on a Successful
Transition from Pediatric to Adult Care in Sickle Cell Disease.Journal of Hematology Research. 2016;2(1):17-24.
27. Haywood C, Lanzkron S, Bediako S, et al. Perceived Discrimination,
Patient Trust, and Adherence to Medical Recommendations Among Persons
with Sickle Cell Disease. Journal of General Internal Medicine.2014;29(12):1657-1662.
28. Porter JS, Wesley KM, Zhao MS, Rupff RJ, Hankins JS. Pediatric to
Adult Care Transition: Perspectives of Young Adults With Sickle Cell
Disease. Journal of Pediatric Psychology. 2017;42(9):1016-1027.
29. Puri Singh A, Haywood C, Beach MC, et al. Improving Emergency
Providers’ Attitudes Toward Sickle Cell Patients in Pain. Journal
of Pain and Symptom Management. 2016;51(3):628-632.e623.
30. Shankar SM, Arbogast PG, Mitchel E, Ding H, Wang WC, Griffin MR.
Impact of proximity to comprehensive sickle cell center on utilization
of healthcare services among children with sickle cell disease.Pediatric Blood & Cancer. 2008;50(1):66-71.
31. Blinder MA, Duh MS, Sasane M, Trahey A, Paley C, Vekeman F.
Age-Related Emergency Department Reliance in Patients with Sickle Cell
Disease. The Journal of Emergency Medicine.2015;49(4):513-522.e511.
32. Hemker BG, Brousseau DC, Yan K, Hoffmann RG, Panepinto JA. When
children with sickle-cell disease become adults: Lack of outpatient care
leads to increased use of the emergency department. American
Journal of Hematology. 2011;86(10):863-865.
33. Okpala I, Thomas V, Westerdale N, et al. The comprehensive care of
sickle cell disease. European Journal of Haematology.2002;68(3):157-162.
34. Cronin RM, Hankins JS, Byrd J, et al. Risk factors for
hospitalizations and readmissions among individuals with sickle cell
disease: results of a U.S. survey study. Hematology.2019;24(1):189-198.
35. Blinder MA, Vekeman F, Sasane M, Trahey A, Paley C, Duh MS.
Age-related treatment patterns in sickle cell disease patients and the
associated sickle cell complications and healthcare costs.Pediatric Blood & Cancer. 2013;60(5):828-835.
36. Thom DH, Ribisl KM, Stewart AL, Luke DA. Further validation and
reliability testing of the Trust in Physician Scale. The Stanford Trust
Study Physicians. Med Care. 1999;37(5):510-517.
37. Hankins JS, Osarogiagbon R, Adams-Graves P, et al. A Transition
Pilot Program for Adolescents With Sickle Cell Disease. Journal of
Pediatric Health Care. 2012;26(6):e45-e49.